1314008-27-9 Ipflufenoquin 98%

ACE BioSciences is an emerging pharmaceutical company focused on developing novel, protein-based vaccines and antibodies to address infectious diseases caused by bacteria.

ACE BioSciences' competitive advantage is founded on its unique expertise in the extraction and analysis of the cell surface proteins used by pathogens to interact with and infect human host cells.

Our company understands the technology and medicine in the health care industry is consistently progressing. Our team of experienced professionals  stay current about the latest drug trends.

Our team is constantly keeping up with medical trends and technology and strive to find better ways to improve the health of our patients in an ever-changing industry.